[1] Hong SB,Lee MH.Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris[J].Photodermatol Photoimmunol Photomed,2005,21:322-325.

[2] Donnelly RF,McCarron PA,Lightowler JM,et al.Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis[J].J Control Release,2005,103:381-392.

[3] Simkin GO,King DE,Levy JG,et al.Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative[J].Immunopharmacology,1997,37:221-230.

[4] Musser DA,Camacho SH,Manderscheid PA,et al.The anatomic site of photodynamic therapy is a determinant for immunosuppression in a rourine model[J].Photochem Photobiol,1999,69:222-225.

[5] 顾瑛,刘凡光,王开,等.光动力疗法治疗鲜红斑痣1216例临床分析[J].中国激光医学杂志,2001,10:86-89.

[6] 顾瑛,李峻亨,许德余,等,新型光敏剂-血卟啉单甲醚临床应用研究的初步报道[J].中国激光医学杂志,1993,2:235-236.

[7] Elmets C,Bowen K.Immunological suppression in mice treated with hematoporphyrin derivative photoradiation[J].Cancer Res,1986,46:1608-1611.

[8] Bergstresser PR.Immune mechanisms in contact allergic dermatitis[J].Dermatol Clin,1990,8:3-11.

[9] Jolles CJ,Ott MJ,Straight RC,et al.Systemic immunosuppression induced by peritoneal photodynamic therapy[J].Am J Obstet Gynecol,1988,158:1446-1453.

[10] Musser DA,Oseroff AR.Characteristics of the immunosuppression induced by cutaneous photodyrnamic therapy:persistence,antigen specificity and cell type involved[J].Photochem Photobiol,2001,73:518-524.

[11] Richter AM,Jain AK,Obochi M,et al.Activation of benzoporphyrin derivative in the circulation of mice without skin photosensitivity[J].Photochem Photobiol,1994,59:350-355.

[12] Korbelik M,Naraparaju VR,Yamamoto N.Macrophagedirected immunotherapy as adjuvant to photodynamic therapy of cancer[J].Br J Cancer,1997,75:202-207.